Protagonist Therapeutics Inc (PTGX)

Financial leverage ratio

Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019
Total assets US$ in thousands 629,276 357,951 330,016 320,466 239,858 247,928 282,174 310,512 348,296 347,695 373,175 404,232 298,072 324,468 217,320 224,980 134,901 154,917 154,627 148,105
Total stockholders’ equity US$ in thousands 560,444 336,677 302,149 294,068 216,167 215,608 243,616 267,978 301,778 300,021 329,660 357,447 259,334 279,606 169,590 167,485 62,666 79,964 95,358 84,316
Financial leverage ratio 1.12 1.06 1.09 1.09 1.11 1.15 1.16 1.16 1.15 1.16 1.13 1.13 1.15 1.16 1.28 1.34 2.15 1.94 1.62 1.76

March 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $629,276K ÷ $560,444K
= 1.12

The financial leverage ratio of Protagonist Therapeutics Inc has shown fluctuations over the past few quarters. The ratio increased steadily from Jun 2020 to Mar 2021, reaching a peak of 2.15 in Mar 2020, indicating high financial leverage during that period. However, from Mar 2021 onwards, the ratio started to decrease steadily, with occasional fluctuations, reaching a low of 1.06 in Dec 2023. This decrease suggests a reduction in financial risk and reliance on debt financing. Overall, the trend indicates that the company has been managing its debt levels effectively and has gradually improved its financial leverage position.


Peer comparison

Mar 31, 2024